ANTIDotE: Anti-tick vaccines to prevent tick-borne diseases in Europe

44Citations
Citations of this article
116Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Ixodes ricinus transmits bacterial, protozoal and viral pathogens, causing disease and forming an increasing health concern in Europe. ANTIDotE is an European Commission funded consortium of seven institutes, which aims to identify and characterize tick proteins involved in feeding and pathogen transmission. The knowledge gained will be used to develop and evaluate anti-tick vaccines that may prevent multiple human tick-borne diseases. Strategies encompassing anti-tick vaccines to prevent transmission of pathogens to humans, animals or wildlife will be developed with relevant stakeholders with the ultimate aim of reducing the incidence of tick-borne diseases in humans. © 2014 Sprong et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Sprong, H., Trentelman, J., Seemann, I., Grubhoffer, L., Rego, R. O. M., Hajdušek, O., … Hovius, J. W. R. (2014). ANTIDotE: Anti-tick vaccines to prevent tick-borne diseases in Europe. Parasites and Vectors, 7(1). https://doi.org/10.1186/1756-3305-7-77

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free